ClearPoint Neuro, Inc.
CLPT
$14.90
$0.332.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 25.86% | 25.99% | 17.78% | 12.83% | 19.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.86% | 25.99% | 17.78% | 12.83% | 19.68% |
| Cost of Revenue | 18.90% | 22.32% | 16.39% | 10.17% | 17.98% |
| Gross Profit | 30.41% | 28.32% | 18.67% | 14.57% | 20.82% |
| SG&A Expenses | 37.11% | 23.67% | 17.74% | 17.07% | 18.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.20% | 21.10% | 16.06% | 15.95% | 20.63% |
| Operating Income | -29.18% | -13.83% | -13.33% | -21.01% | -22.08% |
| Income Before Tax | -55.80% | -39.67% | -34.83% | -27.72% | -23.65% |
| Income Tax Expenses | -172.00% | 200.00% | 358.33% | -56.82% | -16.67% |
| Earnings from Continuing Operations | -55.54% | -39.78% | -35.03% | -27.51% | -23.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.54% | -39.78% | -35.03% | -27.51% | -23.58% |
| EBIT | -29.18% | -13.83% | -13.33% | -21.01% | -22.08% |
| EBITDA | -30.40% | -13.27% | -14.54% | -22.76% | -22.05% |
| EPS Basic | -47.12% | -33.66% | -28.93% | -19.54% | -13.21% |
| Normalized Basic EPS | -39.55% | -25.22% | -19.79% | -19.72% | -13.28% |
| EPS Diluted | -47.12% | -33.66% | -28.93% | -19.54% | -13.21% |
| Normalized Diluted EPS | -39.55% | -25.22% | -19.79% | -19.72% | -13.28% |
| Average Basic Shares Outstanding | 5.24% | 4.27% | 4.76% | 6.52% | 8.79% |
| Average Diluted Shares Outstanding | 5.24% | 4.27% | 4.76% | 6.52% | 8.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |